Mary J. Christoph, PhD, MPH

Gilead Sciences, Inc.

Disclosure(s): AstraZeneca: Advisor/Consultant, Employee, Stocks/Bonds (Public Company); Gilead Sciences, Inc.: Employee, Stocks/Bonds (Public Company)

Poster(s):

• (P-390) Persistence and Adherence of People With HIV (PWH) and Mental Health Disorder Diagnosis Who Restart Antiretroviral Therapy (ART)
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-393) Treatment Switch among Medicare-insured People with HIV and Gaps in Care
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-394) Antiretroviral therapy persistence following a change or restart in regimen among people with HIV
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET